Evaluating response to immunotherapy with 18F-FDG PET/CT: where do we stand? Nicolas AideMichel De PontdevilleEgesta Lopci Editorial 30 January 2020 Pages: 1019 - 1021
Imaging features of 2019 novel coronavirus pneumonia Xi XuChengcheng YuJinxin Liu Letter to the Editor 14 February 2020 Pages: 1022 - 1023
“Luke! Luke! Don’t! It’s a trap!”—spotlight on bias in animal experiments in nuclear oncology Julie NonnekensMargret Schottelius Letter to the Editor Open access 10 February 2020 Pages: 1024 - 1026
In vivo three-dimensional evaluation of tumour hypoxia in nasopharyngeal carcinomas using FMT-CT and MSOT Wenhui HuangKun WangShuixing Zhang Original Article Open access 08 November 2019 Pages: 1027 - 1038
High nodal FDG uptake increases risk of distant metastasis in patients with oropharyngeal squamous cell carcinoma Jakob Schmidt JensenJulie Thor ChristensenJacob Høygaard Rasmussen Original Article 13 November 2019 Pages: 1039 - 1045
Correlative analyses between tissue-based hypoxia biomarkers and hypoxia PET imaging in head and neck cancer patients during radiochemotherapy—results from a prospective trial Nils H. NicolayNicole WiedenmannGian Kayser Original Article 07 December 2019 Pages: 1046 - 1055
Textural features of hypoxia PET predict survival in head and neck cancer during chemoradiotherapy A. SörensenM. CarlesM. Mix Original Article 26 November 2019 Pages: 1056 - 1064
Usefulness of [18F]fluorodeoxyglucose PET/CT for evaluating the PD-L1 status in nasopharyngeal carcinoma Liang ZhaoYanzhen ZhuangQin Lin Original Article 14 December 2020 Pages: 1065 - 1074
Quantification of 18F-fluorodeoxyglucose uptake to detect residual nodal disease in locally advanced head and neck squamous cell carcinoma after chemoradiotherapy: results from the ECLYPS study Nils HelsenTim Van den WyngaertKristof Deben Original Article 10 February 2020 Pages: 1075 - 1082
18F-FDG PET/CT in diagnostic and prognostic evaluation of patients with cardiac masses: a retrospective study Chunxia QinFuqiang ShaoXiaoli Lan Original Article 05 December 2019 Pages: 1083 - 1093
The feasibility of quantitative parameters of lymphoscintigraphy without significant dermal backflow for the evaluation of lymphedema in post-operative patients with breast cancer Keunyoung KimIn-Joo KimJin A Yoon Original Article 16 November 2019 Pages: 1094 - 1102
Biological correlates of tumor perfusion and its heterogeneity in newly diagnosed breast cancer using dynamic first-pass 18F-FDG PET/CT Neree PayanBenoit PreslesAlexandre Cochet Original Article 08 August 2019 Pages: 1103 - 1115
18F-FDG PET/CT radiomic predictors of pathologic complete response (pCR) to neoadjuvant chemotherapy in breast cancer patients Panli LiXiuying WangGang Huang Original Article 25 January 2020 Pages: 1116 - 1126
New insight on the correlation of metabolic status on 18F-FDG PET/CT with immune marker expression in patients with non-small cell lung cancer Yang WangNing ZhaoXiubao Ren Original Article 09 September 2019 Pages: 1127 - 1136
Value of pre-therapy 18F-FDG PET/CT radiomics in predicting EGFR mutation status in patients with non-small cell lung cancer Jianyuan ZhangXinming ZhaoJingya Han Original Article 14 November 2019 Pages: 1137 - 1146
Baseline metabolic tumor burden on FDG PET/CT scans predicts outcome in advanced NSCLC patients treated with immune checkpoint inhibitors Romain-David SebanLaura MezquitaBenjamin Besse Original Article 21 November 2019 Pages: 1147 - 1157
18FDG PET/CT in the early assessment of non-small cell lung cancer response to immunotherapy: frequency and clinical significance of atypical evolutive patterns O. HumbertN. CadourJ. Otto Original Article 23 November 2019 Pages: 1158 - 1167
Radiomics of 18F-FDG PET/CT images predicts clinical benefit of advanced NSCLC patients to checkpoint blockade immunotherapy Wei MuIlke TunaliRobert J. Gillies Original Article 05 December 2019 Pages: 1168 - 1182
Correlation between combining 18F–FDG PET/CT metabolic parameters and other clinical features and ALK or ROS1 fusion in patients with non-small-cell lung cancer Maomei RuanLiu LiuWenhui Xie Original Article 03 January 2020 Pages: 1183 - 1197
Influx rate constant of 18F-FDG increases in metastatic lymph nodes of non-small cell lung cancer patients Min YangZhong LinHongjun Jin Original Article 23 January 2020 Pages: 1198 - 1208
The efficiency of 18F-FDG PET-CT for predicting the major pathologic response to the neoadjuvant PD-1 blockade in resectable non-small cell lung cancer Xiuli TaoNing LiZewei Zhang Original Article Open access 11 February 2020 Pages: 1209 - 1219
Prognostic significance of semi-quantitative FDG-PET parameters in stage I non-small cell lung cancer treated with carbon-ion radiotherapy Suman ShresthaTetsuya HiguchiYoshito Tsushima Original Article Open access 22 November 2019 Pages: 1220 - 1227
The role of 18F-FDG-PET/CT in predicting the histopathological response in locally advanced cervical carcinoma treated by chemo-radiotherapy followed by radical surgery: a prospective study Vittoria RufiniAngela CollarinoAlessandro Giordano Original Article 14 August 2019 Pages: 1228 - 1238
[18F]Fluciclatide PET as a biomarker of response to combination therapy of pazopanib and paclitaxel in platinum-resistant/refractory ovarian cancer Rohini SharmaPablo Oriol VallsEric O. Aboagye Original Article Open access 21 November 2019 Pages: 1239 - 1251
Tumour and pelvic lymph node metabolic activity on FDG-PET/CT to stratify patients for para-aortic surgical staging in locally advanced cervical cancer A. MartinezM. VoglimacciE. Gabiache Original Article 08 January 2020 Pages: 1252 - 1260
Lymphoscintigraphy and sentinel lymph node biopsy in vulvar carcinoma: update from a European expert panel Angela CollarinoValentina FuocoMarco Maccauro Review Article 02 January 2020 Pages: 1261 - 1274
Imaging and clinical features of patients with 2019 novel coronavirus SARS-CoV-2 Xi XuChengcheng YuJinxin Liu Original Article 28 February 2020 Pages: 1275 - 1280
18F-FDG PET/CT findings of COVID-19: a series of four highly suspected cases Chunxia QinFang LiuXiaoli Lan Short Communication 22 February 2020 Pages: 1281 - 1286
Diagnostic performance of 18F-FDG PET/CT in patients with spinal infection: a systematic review and a bivariate meta-analysis Giorgio TregliaMariarosa PascaleAndor W. J. M. Glaudemans Review Article 15 November 2019 Pages: 1287 - 1301
Quantitative PET imaging of PD-L1 expression in xenograft and syngeneic tumour models using a site-specifically labelled PD-L1 antibody Camilla ChristensenLotte K. KristensenAndreas Kjaer Original Article Open access 27 December 2019 Pages: 1302 - 1313
Using immuno-PET imaging to monitor kinetics of T cell-mediated inflammation and treatment efficiency in a humanized mouse model for GvHD Stefanie PektorJanine SchlöderMatthias Miederer Original Article 31 August 2019 Pages: 1314 - 1325
McCune-Albright syndrome confirmed by 99mTc-MDP Ruiguo ZhangPeng WangJian Tan Image of the Month 13 September 2019 Pages: 1326 - 1328
Augmented planar bone scintigraphy obtained from a whole-body SPECT recording of less than 20 min with a high-sensitivity 360° CZT camera Saifeddine MelkiMohammad Bilal ChawkiAntoine Verger Image of the Month 12 October 2019 Pages: 1329 - 1331
